These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 6580097)
1. Inhibition of first-pass metabolism in cancer chemotherapy: interaction of 6-mercaptopurine and allopurinol. Zimm S; Collins JM; O'Neill D; Chabner BA; Poplack DG Clin Pharmacol Ther; 1983 Dec; 34(6):810-7. PubMed ID: 6580097 [TBL] [Abstract][Full Text] [Related]
2. The effect of methotrexate on the bioavailability of oral 6-mercaptopurine. Balis FM; Holcenberg JS; Zimm S; Tubergen D; Collins JM; Murphy RF; Gilchrist GS; Hammond D; Poplack DG Clin Pharmacol Ther; 1987 Apr; 41(4):384-7. PubMed ID: 3470165 [TBL] [Abstract][Full Text] [Related]
3. The pharmacology of orally administered chemotherapy. A reappraisal. Poplack DG; Balis FM; Zimm S Cancer; 1986 Jul; 58(2 Suppl):473-80. PubMed ID: 3459570 [TBL] [Abstract][Full Text] [Related]
4. Comparative bioavailability and pharmacokinetic studies of azathioprine and 6-mercaptopurine in the rhesus monkey. Ding TL; Benet LZ Drug Metab Dispos; 1979; 7(6):373-7. PubMed ID: 43222 [TBL] [Abstract][Full Text] [Related]
5. Effect of allopurinol on the first-pass metabolism of 6-mercaptopurine in the rat. Sasaki H; Tsuru K; Nakamura J; Konishi R; Shibasaki J Biochem Pharmacol; 1987 Dec; 36(23):4175-6. PubMed ID: 3689444 [No Abstract] [Full Text] [Related]
6. Influence of food intake on bioavailability of oral 6-mercaptopurine in children with acute lymphoblastic leukemia. Riccardi R; Balis FM; Ferrara P; Lasorella A; Poplack DG; Mastrangelo R Pediatr Hematol Oncol; 1986; 3(4):319-24. PubMed ID: 3153245 [TBL] [Abstract][Full Text] [Related]
7. Effect of allopurinol on the intestinal absorption of 6-mercaptopurine in rats. Sasaki H; Tsuru K; Nakamura J; Konishi R; Shibasaki J J Pharmacobiodyn; 1987 Dec; 10(12):697-702. PubMed ID: 3451956 [TBL] [Abstract][Full Text] [Related]
8. Metabolism of intravenously administered high-dose 6-mercaptopurine with and without allopurinol treatment in patients with non-Hodgkin lymphoma. Keuzenkamp-Jansen CW; DeAbreu RA; Bökkerink JP; Lambooy MA; Trijbels JM J Pediatr Hematol Oncol; 1996 May; 18(2):145-50. PubMed ID: 8846126 [TBL] [Abstract][Full Text] [Related]
9. Serum azathioprine and 6-mercaptopurine levels and immunosuppressive activity after azathioprine in uremic patients. Odlind B; Hartvig P; Lindström B; Lönnerholm G; Tufveson G; Grefberg N Int J Immunopharmacol; 1986; 8(1):1-11. PubMed ID: 3957504 [TBL] [Abstract][Full Text] [Related]
10. Plasma and erythrocyte concentrations of mercaptopurine after oral administration in children. Lönnerholm G; Kreuger A; Lindström B; Ludvigsson J; Myrdal U Pediatr Hematol Oncol; 1986; 3(1):27-35. PubMed ID: 3153216 [TBL] [Abstract][Full Text] [Related]
11. A prospective evaluation of the impact of allopurinol in pediatric and adult IBD patients with preferential metabolism of 6-mercaptopurine to 6-methylmercaptopurine. Gerich ME; Quiros JA; Marcin JP; Tennyson L; Henthorn M; Prindiville TP J Crohns Colitis; 2010 Nov; 4(5):546-52. PubMed ID: 21122558 [TBL] [Abstract][Full Text] [Related]
12. Kinetics of allopurinol after single intravenous and oral doses. Noninteraction with benzbromarone and hydrochlorothiazide. Breithaupt B; Tittel M Eur J Clin Pharmacol; 1982; 22(1):77-84. PubMed ID: 7094977 [TBL] [Abstract][Full Text] [Related]
13. Acute lymphocytic leukemia in a child with congenital xanthine oxidase deficiency: implications for therapy. Morgan E; Honig G; Nelson DJ Am J Pediatr Hematol Oncol; 1981; 3(4):439-41. PubMed ID: 6949480 [TBL] [Abstract][Full Text] [Related]
14. Use of allopurinol in children with acute lymphoblastic leukemia to reduce skewed thiopurine metabolism. Brackett J; Schafer ES; Leung DH; Bernhardt MB Pediatr Blood Cancer; 2014 Jun; 61(6):1114-7. PubMed ID: 24376133 [TBL] [Abstract][Full Text] [Related]
15. Rectal bioavailability of 6-mercaptopurine in children with acute lymphoblastic leukaemia: partial avoidance of "first-pass" metabolism. Kato Y; Matsushita T; Uchida H; Egi S; Yokoyama T; Mohri K Eur J Clin Pharmacol; 1992; 42(6):619-22. PubMed ID: 1623901 [TBL] [Abstract][Full Text] [Related]
16. Clinical and experimental pharmacokinetic interaction between 6-mercaptopurine and methotrexate. Innocenti F; Danesi R; Di Paolo A; Loru B; Favre C; Nardi M; Bocci G; Nardini D; Macchia P; Del Tacca M Cancer Chemother Pharmacol; 1996; 37(5):409-14. PubMed ID: 8599862 [TBL] [Abstract][Full Text] [Related]
17. Variable bioavailability of oral mercaptopurine. Is maintenance chemotherapy in acute lymphoblastic leukemia being optimally delivered? Zimm S; Collins JM; Riccardi R; O'Neill D; Narang PK; Chabner B; Poplack DG N Engl J Med; 1983 Apr; 308(17):1005-9. PubMed ID: 6572786 [No Abstract] [Full Text] [Related]
18. The effect of cotrimoxazole on the absorption of orally administered 6-mercaptopurine in the rat. Burton NK; Aherne GW Cancer Chemother Pharmacol; 1986; 16(1):83-4. PubMed ID: 3484383 [TBL] [Abstract][Full Text] [Related]
19. Effect of allopurinol on clinical outcomes in inflammatory bowel disease nonresponders to azathioprine or 6-mercaptopurine. Sparrow MP; Hande SA; Friedman S; Cao D; Hanauer SB Clin Gastroenterol Hepatol; 2007 Feb; 5(2):209-14. PubMed ID: 17296529 [TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetic determinants of 6-mercaptopurine myelotoxicity and therapeutic failure in children with acute lymphoblastic leukemia. Sulh H; Koren G; Whalen C; Soldin S; Zipursky A; Greenberg M Clin Pharmacol Ther; 1986 Dec; 40(6):604-9. PubMed ID: 3465489 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]